Therapy Areas: Inflammatory Diseases
16 November 2018 - - US-based pharmaceutical company KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has provided an update on the hereditary angioedema candidate KVD900, the company said.

...
15 November 2018 - - French biopharmaceutical company Poxel SA (Euronext: POXEL - FR0012432516) made presentations for PXL770 and PXL065 (formerly DRX-065; acquired from DeuteRx LLC) showing prom...
14 November 2018 - - Canadian macrophage-driven inflammation specialist Mperia Therapeutics' board of directors has appointed Paul Chipperton, as the company's new president and CEO, effecti...
13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented new data from the company's clinical development programme for advanced fibrosis due to ...
13 November 2018 - - US-based immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has advanced its oncology programme, the company said.

Following promising preclinical data...
13 November 2018 - - US-based biopharmaceutical company Omeros Corp. (NASDAQ: OMER) has priced an offering of USD 210m aggregate principal amount of its 6.25% convertible senior notes due 2023 in a pr...
Related Headlines